Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes
dc.contributor.author | Kempler, Peter | en_US |
dc.contributor.author | Amarenco, G. | en_US |
dc.contributor.author | Freeman, R. | en_US |
dc.contributor.author | Frontoni, Simona | en_US |
dc.contributor.author | Horowitz, M. | en_US |
dc.contributor.author | Stevens, Martin J. | en_US |
dc.contributor.author | Low, Phillip A. | en_US |
dc.contributor.author | Pop‐busui, R. | en_US |
dc.contributor.author | Tahrani, A. A. | en_US |
dc.contributor.author | Tesfaye, Solomon | en_US |
dc.contributor.author | Várkonyi, T. | en_US |
dc.contributor.author | Ziegler, D. | en_US |
dc.contributor.author | Valensi, Paul | en_US |
dc.date.accessioned | 2011-11-10T15:37:19Z | |
dc.date.available | 2012-12-03T21:17:30Z | en_US |
dc.date.issued | 2011-10 | en_US |
dc.identifier.citation | Kempler, P.; Amarenco, G.; Freeman, R.; Frontoni, S.; Horowitz, M.; Stevens, M.; Low, P.; Pop‐busui, R. ; Tahrani, A. A.; Tesfaye, S.; Várkonyi, T. ; Ziegler, D.; Valensi, P. (2011). "Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes." Diabetes/Metabolism Research and Reviews 27(7): 665-677. <http://hdl.handle.net/2027.42/87058> | en_US |
dc.identifier.issn | 1520-7552 | en_US |
dc.identifier.issn | 1520-7560 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/87058 | |
dc.description.abstract | There are substantial advances in understanding disordered gastrointestinal autonomic dysfunction in diabetes. It occurs frequently. The underlying pathogenesis is complex involving defects in multiple interacting cell types of the myenteric plexus as well. These defects may be irreversible or reversible. Gastrointestinal symptoms represent a major and generally underestimated source of morbidity for escalating health care costs in diabetes. Acute changes in glycaemia are both determinants and consequences of altered gastrointestinal motility. 35–90% of diabetic men have moderate‐to‐severe erectile dysfunction (ED). ED shares common risk factors with CVD. Diagnosis is based on medical/sexual history, including validated questionnaires. Physical examination and laboratory testing must be tailored to patient's complaints and risk factors. Treatment is based on PDE5‐inhibitors (PDE5‐I). Other explorations may be useful in patients who do not respond to PDE5‐I. Patients at high cardiovascular risk should be stabilized by their cardiologists before sexual activity is considered or ED treatment is recommended. Estimates on bladder dysfunction prevalence are 43–87% of type 1 and 25% of type 2 diabetic patients, respectively. Common symptoms include dysuria, frequency, urgency, nocturia and incomplete bladder emptying. Diagnosis should use validated questionnaire for lower urinary tract symptoms. The type of bladder dysfunction is readily characterized with complete urodynamic testing. Sudomotor dysfunction is a cause of dry skin and is associated with foot ulcerations. Sudomotor function can be assessed by thermoregulatory sweat testing, quantitative sudomotor axon reflex test, sympathetic skin response, quantitative direct/indirect axon reflex testing and the indicator plaster. Copyright © 2011 John Wiley & Sons, Ltd. | en_US |
dc.publisher | John Wiley & Sons, Ltd. | en_US |
dc.subject.other | Gastroparesis | en_US |
dc.subject.other | Gastrointestinal Autonomic Neuropathy | en_US |
dc.subject.other | Erectile Dysfunction | en_US |
dc.subject.other | Sudomotor Dysfunction | en_US |
dc.subject.other | Bladder Dysfunction | en_US |
dc.title | Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Metabolism, Endocrinology and Diabetes, Brehm Center for Diabetes Research, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | I Department of Medicine, Semmelweis University, Budapest, Hungary | en_US |
dc.contributor.affiliationother | Service de Neuro‐Urologie, Hôpital Tenon, Assistance Publique‐Hôpitaux de Paris, Paris, France | en_US |
dc.contributor.affiliationother | Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA | en_US |
dc.contributor.affiliationother | Department of Internal Medicine, University of Tor Vergata, Rome, Italy | en_US |
dc.contributor.affiliationother | Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia | en_US |
dc.contributor.affiliationother | Department of Medicine, University of Birmingham, Birmingham, UK | en_US |
dc.contributor.affiliationother | Mayo Clinic, Rochester, MN, USA | en_US |
dc.contributor.affiliationother | Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK | en_US |
dc.contributor.affiliationother | School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK | en_US |
dc.contributor.affiliationother | Diabetes Research Unit, Sheffield Teaching Hospitals, Sheffield, UK | en_US |
dc.contributor.affiliationother | First Department of Medicine, University of Szeged, Szeged, Hungary | en_US |
dc.contributor.affiliationother | Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, Düsseldorf, Germany | en_US |
dc.contributor.affiliationother | Department of Metabolic Diseases, University Hospital, Düsseldorf, Germany | en_US |
dc.contributor.affiliationother | Service d'Endocrinologie‐Diabétologie‐Nutrition, AP‐HP, Hôpital Jean Verdier, Paris‐Nord University, CRNH‐IdF, Bondy, France | en_US |
dc.contributor.affiliationother | I Department of Medicine, Semmelweis University, 1083 Budapest, Korányi Sándor u. 2/a, Hungary. | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/87058/1/1223_ftp.pdf | |
dc.identifier.doi | 10.1002/dmrr.1223 | en_US |
dc.identifier.source | Diabetes/Metabolism Research and Reviews | en_US |
dc.identifier.citedreference | Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJ. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18 ( 4 ): 229 – 234. | en_US |
dc.identifier.citedreference | Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127 ( 5 ): 1592 – 1622. | en_US |
dc.identifier.citedreference | Bharucha AE, Camelleri M, Forstrom LA, Zinsmeister A. Relationship between clinical features and gastric emptying disturbance in diabetes mellitus. Clin Endocrinol 2009; 70: 415 – 420. | en_US |
dc.identifier.citedreference | Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population‐based survey of 15 000 adults. Arch Intern Med 2001; 161: 1989 – 1996. | en_US |
dc.identifier.citedreference | Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24 ( 2 ): 371 – 381. | en_US |
dc.identifier.citedreference | Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993; 36: 857 – 862. | en_US |
dc.identifier.citedreference | Horowitz M, Jones KL, Rayner CK, Read NW. 'Gastric' hypoglycaemia: an important concept in diabetes management. Neurogastroenterol Motil 2006; 18: 405 – 407. | en_US |
dc.identifier.citedreference | Phillips LK, Rayner CK, Jones KL, Horowitz M. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep 2006; 6: 417 – 423. | en_US |
dc.identifier.citedreference | Pasricha PJ, Pehlivanov ND, Gomez G, Vittal H, Lurken MS, Farrugia G. Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis. BMC Gastroenterol 2008; 8: 21. | en_US |
dc.identifier.citedreference | Khoo J, Rayner CK, Jones KL, Horowitz M. Pathophysiology and management of gastroparesis. Exp Rev Gastroenterol Hepatol 2009; 3: 167 – 181. | en_US |
dc.identifier.citedreference | Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin‐dependent diabetes mellitus. Gastroenterology 1997; 113: 60 – 66. | en_US |
dc.identifier.citedreference | Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24: 1264 – 1269. | en_US |
dc.identifier.citedreference | Camilleri M, Bharucha AE, Lorenzo C, et al. Amerian Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008; 20: 1269 – 1282. | en_US |
dc.identifier.citedreference | Jones KL, Berry M, Kong MF, Kwiatek MA, Samsom M, Horowitz M. Hyperglycaemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 1999; 22: 339 – 344. | en_US |
dc.identifier.citedreference | Sturm A, Holtmann G, Goebell H, Gerken C. Prokentics in patients with gastroparesis: a systematic analysis. Digestion 1999; 60: 422 – 427. | en_US |
dc.identifier.citedreference | McCallum RW, Snape W, Brady F, Wa J, Parkman HP, Nowak T. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 2010; 8: 947 – 954. | en_US |
dc.identifier.citedreference | Samson M, Verhagen M. Intestinal function. In Gastrointestinal Function in Diabetes Mellitus, Horowitz M, Samsom M (eds). Chichester: John Wiley and Sons: 2004; 177 – 217. | en_US |
dc.identifier.citedreference | Ma J, Stevens JE, Cukier K, et al. Effects of a protein preload on gastric emptying, glycaemia and gut hormones after a carbohydrate meal in diet controlled type 2 diabetes. Diabetes Care 2009; 32: 1600 – 1602. | en_US |
dc.identifier.citedreference | Linnebjerg H, Park S, Kothare PA, et al. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept 2008; 151: 123 – 129. | en_US |
dc.identifier.citedreference | Sun P, Cameron A, Seftel A, Shabsigh R, Niederberger C, Guay A. Erectile dysfunction—an observable marker of diabetes mellitus? A large national epidemiological study. J Urol 2006; 176: 1081 – 1085. | en_US |
dc.identifier.citedreference | Nicolosi A, Glasser DB, Brock G, Laumann E, Gingell C. Diabetes and sexual function in older adults: results of an international survey. Br J Diabetes Vasc Dis 2002; 2: 336 – 339. | en_US |
dc.identifier.citedreference | Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377 – 1384. | en_US |
dc.identifier.citedreference | Penson DF, Wessells H, Cleary P, Rutledge BN, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sexual dysfunction and symptom impact in men with long‐standing type 1 diabetes in the DCCT/EDIC cohort. J Sex Med 2009; 6: 1969 – 1978. | en_US |
dc.identifier.citedreference | Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460 – 463. | en_US |
dc.identifier.citedreference | Fedele D, Coscelli C, Santeusanio F, et al. Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 1998; 21: 1973 – 1977. | en_US |
dc.identifier.citedreference | Inman BA, Sauver JL, Jacobson DJ, et al. A population‐based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009; 84: 108 – 113. | en_US |
dc.identifier.citedreference | Araujo AB, Travison TG, Ganz P, et al. Erectile dysfunction and mortality. J Sex Med 2009; 6: 2445 – 2454. | en_US |
dc.identifier.citedreference | Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003; 26: 1093 – 1099. | en_US |
dc.identifier.citedreference | De Berardis G, Pellegrini F, Franciosi M, et al. QuED (Quality of Care and Outcomes in Type 2 Diabetes) Study Group Longitudinal assessment of quality of life in patients with type 2 diabetes and self‐reported erectile dysfunction. Diabetes Care 2005; 28: 2637 – 2643. | en_US |
dc.identifier.citedreference | Várkonyi T, Kempler P. Erectile dysfunction. In Diabetes in Old Age (3rd edn), Sinclair A (ed). John Wiley S̈ons: 2009; 149 – 164. | en_US |
dc.identifier.citedreference | Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005; 96: 313 – 321. | en_US |
dc.identifier.citedreference | Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804 – 814. | en_US |
dc.identifier.citedreference | Ziegler D, Merfort F, van Ahlen H, Yassin A, Reblin T, Neureither M. Efficacy and safety of flexible‐dose vardenafil in men with type 1 diabetes and erectile dysfunction. J Sex Med 2006; 3: 883 – 891. | en_US |
dc.identifier.citedreference | Hatzichristou D, Gambla M, Rubio‐Aurioles E, et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med 2008; 25: 138 – 146. | en_US |
dc.identifier.citedreference | Qaseem A, Snow V, Denberg TD, et al. Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Ann Intern Med 2009; 151: 639 – 649. | en_US |
dc.identifier.citedreference | Hill SR, Fayyad AM, Jones GR. Diabetes mellitus and female lower urinary tract symptoms: a review. Neurourol Urodyn 2008; 27: 362 – 367. | en_US |
dc.identifier.citedreference | Esteghamati A, Rashidi A, Nikfallah A, Yousefizadeh A. The association between urodynamic findings and microvascular complications in patients with long‐term type 2 diabetes but without voiding symptoms. Diabetes Res Clin Pract 2007; 78 ( 1 ): 42 – 50. [E‐pub 19 March 2007] | en_US |
dc.identifier.citedreference | Jackson RA, Vittinghoff E, Kanaya AM, et al. Urinary incontinence in elderly women: finding from the Health, Aging, and Body Composition Study. Obstet Gynecol 2004; 104: 301 – 307. | en_US |
dc.identifier.citedreference | Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 2000; 163: 1725 – 1729. | en_US |
dc.identifier.citedreference | Van Den Eeden SK, Sarma AV, Rutledge BN, et al. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care 2009; 32: 664 – 670. | en_US |
dc.identifier.citedreference | Sarma AV, Kanaya A, Nyberg LM, et al. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology 2009; 73 ( 6 ): 1203 – 1209. | en_US |
dc.identifier.citedreference | Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of DM‐associated bladder complications and novel therapy. BJU Int 2005; 95: 733 – 738. | en_US |
dc.identifier.citedreference | Hunter KF, Moore KN. DM‐associated bladder dysfunction in the older adult (CE). Geriatr Nurs (New York, NY) 2003; 24: 138 – 145. | en_US |
dc.identifier.citedreference | Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ. Effects of diabetes on female voiding behavior. J Urol 2004; 172: 989 – 992. | en_US |
dc.identifier.citedreference | Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol 1995; 153: 342 – 344. | en_US |
dc.identifier.citedreference | Szabo L, Barkai L, Lombay B. Urinary flow disturbance as an early sign of autonomic neuropathy in diabetic children and adolescents. Neurourol Urodyn 2007; 26: 218 – 221. | en_US |
dc.identifier.citedreference | Rapidi CA, Karandreas N, Katsifotis C, Benroubi M, Petropoulou K, Theodorou C. A combined urodynamic and electrophysiological study of diabetic cystopathy. Neurourol Urodyn 2006; 25: 32 – 38. | en_US |
dc.identifier.citedreference | Wyndaele JJ, Kovindha A, Madersbacher H, Raddziszewski P, Ruffion A, Schurch B. Neurologic urinary and faecal incontinence. Diabetes Mellitus (916–917). In Incontinence (4th International Consultation on Incontinence) (4th edn), vol 1, Editions 21. Health Publication: Paris, 2009; 1870 p. ISBN 0‐9546956‐8‐2. | en_US |
dc.identifier.citedreference | Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med 2009; 26: 302 – 305. | en_US |
dc.identifier.citedreference | England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence‐based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72: 177 – 184. | en_US |
dc.identifier.citedreference | Illigens B, Gibbons C. Sweat testing to evaluate autonomic function. Clin Auton Res 2009; 19: 79 – 87. | en_US |
dc.identifier.citedreference | Low VA, Sandroni P, Fealey RD, Low PA. Detection of small‐fiber neuropathy by sudomotor testing. Muscle Nerve 2006; 34: 57 – 61. | en_US |
dc.identifier.citedreference | Schnell O, Müller M, Standl E. Early detection of changes in the feet of diabetic patients with indicator test Neuropad. Diabetes Metab Heart 2008; 17: 203 – 210. | en_US |
dc.identifier.citedreference | Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJM, Malik RA. The Neuropad test: a visual indicator test for human diabetic neuropathy. Diabetologia 2008; 51: 1046 – 1050. | en_US |
dc.identifier.citedreference | Low PA, Vernino S, Suarez G. Autonomic dysfunction in peripheral nerve disease. Muscle Nerve 2003; 27: 646 – 661. | en_US |
dc.identifier.citedreference | Al‐Moallem MA, Zaidan RM, Alkali NH. The sympathetic skin response in diabetic neuropathy and its relationship to autonomic symptoms. Saudi Med J 2008; 29: 568 – 572. | en_US |
dc.identifier.citedreference | Turner J, Belch JJF, Khan F. Current concepts in assessment of microvascular endothelial function using laser doppler imaging and iontophoresis. Trends Cardiovasc Med 2008; 18: 109 – 116. | en_US |
dc.identifier.citedreference | Gibbons CH, Illigens BMW, Centi J, Freeman R. QDIRT: Quantitative direct and indirect test of sudomotor function. Neurology 2008; 70: 2299 – 2304. | en_US |
dc.identifier.citedreference | Chao CY, Cheing CL. Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev 2009; 25: 604 – 614. | en_US |
dc.identifier.citedreference | Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 2007; 30: 655 – 659. | en_US |
dc.identifier.citedreference | Hilz MJ, Hecht MJ, Berghoff M, Singer W, Neundoerfer B. Abnormal vasoreaction to arousal stimuli—an early sign of diabetic sympathetic neuropathy demonstrated by laser Doppler flowmetry. J Clin Neurophysiol 2000; 17: 419 – 425. | en_US |
dc.identifier.citedreference | Kim SW, Kim SC, Nam KC, Kang ES, Im JJ, Kim DW. A new method of screening for diabetic neuropathy using laser Doppler and photoplethysmography. Med Biol Eng Comput 2008; 46: 61 – 67. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.